NASDAQ: MNPR Monopar Therapeutics 10-Q

Monopar raises $92M, extends runway to 2027; ALXN1840 NDA delayed to mid-2026

Filed May 14, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade MNPR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.